SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 93.77 |
| Enterprise Value ($M) | 90.67 |
| Book Value ($M) | -40.24 |
| Book Value / Share | -1.33 |
| Price / Book | -2.33 |
| NCAV ($M) | -51.33 |
| NCAV / Share | -1.70 |
| Price / NCAV | -1.83 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -1.25 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.85 |
| Current Ratio | 0.94 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 37.32 |
| Assets | 48.41 |
| Liabilities | 88.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Hirschman Orin | |||
| 13G/A | Nantahala Capital Management, LLC | |||
| 13G | Silverarc Capital Management, Llc | 5.53 | ||
| 13G/A | Birchview Capital, LP | 8.76 | 0.00 | |
| 13D/A | HighCape Capital, L.P. | 48.70 | -28.09 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 4,604 | 27,991 | 16.45 | |
| 1,382 | 8,211 | 16.83 | |
| 2,181 | 15,063 | 14.48 | |
| 3,507 | 18,531 | 18.93 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| EDSA – Edesa Biotech, Inc. | ELDN – Eledon Pharmaceuticals, Inc. |
| ELTX – Elicio Therapeutics, Inc. | ENLV – Enlivex Therapeutics Ltd. |
| ENSC – Ensysce Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io